Professor of Obstetrics and Gynecology and Medicine
Director, Global Health Initiative
- HIV/human papillomavirus (HPV) and cervical cancer screening
- HPV vaccine
- HIV and women
- HIV mother-to-child transmission
- HPV and anogenital dysplasia/cancer
- HIV in the female genital tract
Dr Cu-Uvin is an attending physician at the Miriam Hospital/Brown University specializing in HIV medicine. She served as the Director of the Miriam Immunology Center for 10 years and is currently the Director of the Brown Global Health Initiative. In addition to her clinical duties, Dr Cu-Uvin teaches courses on HIV and sexually transmitted diseases and mentors students, residents, and fellows on HIV-related research. Her research interests include HIV and women, HIV in the female genital tract, and anogenital HPV infection.
- Member, Public Health Service Task Force/Perinatal Antiretroviral Guidelines Working Group, Office of AIDS Research
- Member, NIH/NIAID AIDS Research Review Committee
- Member, Institute of Medicine, National Academy of Sciences Committee on Women’s Health Research
- Member, Institute of Medicine, National Academy of Sciences Committee on HIV Testing
- Group Leader, HPV Working Group, USPHS/IDSA Guidelines for the Prevention and Treatment of Opportunistic Infections
- Bruce M. Selya Annual Award for Research Excellence, Lifespan, Brown University
- Contance B. Wofsy Women’s Health Investigator Award, AIDS Clinical Trials Group
- The Ladies Home Journal Health Breakthrough Awards
- Woman Physician of the Year, Rhode Island Medical Women’s Association
- Rhode Island Woman of the Year, Rhode Island Commission on Women
- University of the Philippines, BS, Zoology (1978)
- University of the Philippines, MD, Medicine (1982)
- Philippine General Hospital, Residency, Obstetrics and Gynecology (1984-1987)
- The Miriam Hospital, Brown University, Fellow, Clinical HIV/AIDS (1992-1995)
- Kojic EM, Cu-Uvin S, Conley L, et al. Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (The SUN Study). Sex Transm Dis. 2010. [Epub ahead of print]
- Cu-Uvin S, DeLong AK, Venkatesh KK, et al. Genital tract HIV-1 RNA shedding among women with below detectable plasma viral load. AIDS. 2010;24:2489-2497.
- Kwara A, Delong A, Rezk N, et al. Antiretroviral drug concentrations and HIV RNA in the genital tract of HIV-infected women receiving long-term highly active antiretroviral therapy. Clin Infect Dis. 2008;46:719-725.
- Cu-Uvin S, Snyder B, Harwell JI, et al. Association between paired plasma and cervicovaginal lavage fluid HIV-1 RNA levels during 36 months. JAIDS. 2006;42:584-587.
- Cu-Uvin S, Ko H, Jamieson DJ, et al. Prevalence, incidence, and persistence or recurrence of trichomoniasis among human immunodeficiency virus (HIV)-positive women and among HIV-negative women at high risk for HIV infection. Clin Infect Dis. 2002;34:1406-1411.
- Cu-Uvin S, Caliendo AM, Reinert S, et al. Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA. AIDS. 2000;14:415-421.
- Cu-Uvin S, Wright DJ, Anderson D, et al. Hormonal levels among HIV-1-seropositive women compared with high-risk HIV-seronegative women during the menstrual cycle. Women's Health Study (WHS) 001 and WHS 001a Study Team. J Womens Health Gend Based Med. 2000;9:857-863.
- Cu-Uvin S, Hogan JW, Warren D, et al. Prevalence of lower genital tract infections among human immunodeficiency virus (HIV)-seropositive and high-risk HIV-seronegative women. HIV Epidemiology Research Study Group. Clin Infect Dis. 1999;29:1145-1150.
- Cu-Uvin SC, Caliendo AM. Cervicovaginal human immunodeficiency virus secretion and plasma viral load in human immunodeficiency virus-seropositive women. Obstet Gynecol. 1997;90:739-743.
- Cu-Uvin S, Flanigan TP, Rich JD, Mileno MD, Mayer KH, Carpenter CC. Human immunodeficiency virus infection and acquired immunodeficiency syndrome among North American women. Am J Med. 1996;101:316-322.